Novel CIC variants identified in individuals with neurodevelopmental phenotypes
Authors:
- Jill A. RosenfeldJRJill A. Rosenfeld
- Anna LehmanALAnna Lehman
- the CAUSES StudyTSthe CAUSES Study
- Qiumin TanQTQiumin Tan
- 14 February 2022
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 43 (7) , 889-899
Abstract
Heterozygous pathogenic variants in CIC, which encodes a transcriptional repressor, have been identified in individuals with neurodevelopmental phenotypes. To date, 11 CIC variants have been associated with the CIC-related neurodevelopmental syndrome. Here, we describe three novel and one previously reported CIC variants in four individuals with neurodevelopmental delay. Notably, we report for the first time a de novo frameshift variant specific to the long isoform of CIC (CIC-L, NM_001304815.1:c.1100dup, p.Pro368AlafsTer16) in an individual with speech delay, intellectual disability and autism spectrum disorder. Our investigation into the function of CIC-L reveals that partial loss of CIC-L leads transcriptional de-repression of CIC target genes. We also describe a missense variant (NM_015125.3:c.683G>A, p.Arg228Gln) in an individual with a history of speech delay and relapsed pre-B acute lymphoblastic leukemia (ALL). Functional studies of this variant suggest a partial loss of CIC transcriptional repressor activity. Our study expands the list of CIC pathogenic variants and contributes to the accumulating evidence that CIC haploinsufficiency or partial loss of function is a pathogenic mechanism causing neurodevelopmental phenotypes.Keywords
Funding Information
- Genome British Columbia
- Natural Sciences and Engineering Research Council of Canada (RGPIN‐2019‐06153)
- Canadian Institutes of Health Research (PJT‐178103)
- Canada Foundation for Innovation (38985)
- Canada Research Chairs
- Institute of Human Development, Child and Youth Health (MRC‐177440)
This publication has 19 references indexed in Scilit:
- The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone DeacetylationCancer Research, 2018
- Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphomaProceedings of the National Academy of Sciences, 2018
- Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphomaGenes & Development, 2017
- Disruption of the ATXN1–CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humansNature Genetics, 2017
- Genetically engineered mouse models of human B-cell precursor leukemiasCell Cycle, 2014
- Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and CapicuaGenes & Development, 2013
- A de novo paradigm for mental retardationNature Genetics, 2010
- An in vitro recombination method to convert restriction‐ and ligation‐independent expression vectorsBiotechnology Journal, 2008
- Current management and challenges of malignant disease in the CNS in paediatric leukaemiaThe Lancet Oncology, 2008
- ATAXIN-1 Interacts with the Repressor Capicua in Its Native Complex to Cause SCA1 NeuropathologyCell, 2006